Fresh guidance provided by Ansell at its AGM implies a 40/60 skew in earnings to the second half compared to a 45/55 average over FY15-19. Macquarie sees price as a more relative factor in the 2H and on current dynamics, retains Sell.The broker had previously highlighted the benefit of price increases over and above dollar cost pass-through, primarily for examination and single-use products, based on recent trends now sees downside risk to FY22 guidance and consensus expectations.Target falls to $30.70 from $32.00.Sector: Health Care Equipment & Services. Target price is $30.70.Current Price is $30.52. Difference: $0.18 – (brackets indicate current price is over target). If ANN meets the Macquarie target it will return approximately 1% (excluding dividends, fees and charges – negative figures indicate an expected loss).
- Forums
- ASX - By Stock
- ANN
- Ann: Ansell Limited FY22 Trading and Business Update
Ann: Ansell Limited FY22 Trading and Business Update, page-12
- There are more pages in this discussion • 39 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add ANN (ASX) to my watchlist
(20min delay)
|
|||||
Last
$25.84 |
Change
0.140(0.54%) |
Mkt cap ! $3.771B |
Open | High | Low | Value | Volume |
$25.72 | $25.97 | $25.67 | $5.966M | 230.8K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 1262 | $25.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$25.85 | 873 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 20 | 25.230 |
1 | 250 | 25.110 |
1 | 204 | 25.000 |
1 | 35 | 24.800 |
1 | 400 | 24.580 |
Price($) | Vol. | No. |
---|---|---|
26.000 | 4525 | 9 |
26.100 | 229 | 2 |
26.180 | 360 | 1 |
26.200 | 30 | 1 |
26.250 | 105 | 1 |
Last trade - 16.10pm 07/06/2024 (20 minute delay) ? |
|
|||||
Last
$25.89 |
  |
Change
0.140 ( 0.95 %) |
|||
Open | High | Low | Volume | ||
$25.72 | $25.96 | $25.67 | 38280 | ||
Last updated 15.59pm 07/06/2024 ? |
Featured News
ANN (ASX) Chart |